Total Payments
$3,346
2024 Payments
$598.90
Companies
26
Transactions
179
Medicare Patients
2,204
Medicare Billing
$188,103
Payment Breakdown by Category
Food & Beverage$3,315 (99.1%)
Education$30.47 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,315 | 176 | 99.1% |
| Education | $30.47 | 3 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $492.93 | 19 | $0 (2019) |
| Novo Nordisk Inc | $447.73 | 20 | $0 (2024) |
| GlaxoSmithKline, LLC. | $415.42 | 32 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $275.92 | 11 | $0 (2023) |
| ABBVIE INC. | $231.10 | 19 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $220.14 | 10 | $0 (2024) |
| Astellas Pharma US Inc | $208.84 | 12 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $167.00 | 14 | $0 (2019) |
| 3B Medical, Inc. | $149.11 | 1 | $0 (2024) |
| EKOS Corporation | $109.33 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $598.90 | 30 | 3B Medical, Inc. ($149.11) |
| 2023 | $515.25 | 22 | AstraZeneca Pharmaceuticals LP ($173.49) |
| 2022 | $136.43 | 8 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($61.90) |
| 2021 | $15.22 | 1 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($15.22) |
| 2019 | $580.43 | 34 | Novo Nordisk Inc ($194.56) |
| 2018 | $713.28 | 41 | Novo Nordisk Inc ($182.95) |
| 2017 | $786.03 | 43 | Novartis Pharmaceuticals Corporation ($261.66) |
All Payment Transactions
179 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/21/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $32.68 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | 3B Medical, Inc. | LUNA (Device) | Food and Beverage | Cash or cash equivalent | $149.11 | General |
| Category: VENTILATOR, NON-CONTINUOUS (RESPIRATOR) | ||||||
| 11/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.49 | General |
| Category: PSYCHIATRY | ||||||
| 10/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Obesity | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: PSYCHIATRY | ||||||
| 08/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.68 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.56 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.38 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.11 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.72 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Diabetes | ||||||
| 05/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.05 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.74 | General |
| Category: NEUROSCIENCE | ||||||
| 04/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Biological | ||||||
| 04/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.54 | General |
| Category: NEUROSCIENCE | ||||||
| 03/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.50 | General |
| Category: NEUROSCIENCE | ||||||
| 03/13/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $44.58 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Gastroenterology | ||||||
| 03/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: NEUROSCIENCE | ||||||
| 02/26/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 440 | 667 | $164,423 | $29,782 |
| 2022 | 11 | 529 | 716 | $204,295 | $43,819 |
| 2021 | 13 | 535 | 687 | $166,873 | $48,676 |
| 2020 | 14 | 700 | 903 | $182,040 | $65,825 |
Total Patients
2,204
Total Services
2,973
Medicare Billing
$188,103
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 81 | 90 | $70,697 | $12,041 | 17.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 29 | 56 | $36,400 | $5,007 | 13.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 37 | 40 | $11,600 | $4,030 | 34.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 29 | 33 | $20,833 | $2,814 | 13.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 29 | $13,079 | $1,638 | 12.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 89 | 160 | $2,080 | $1,344 | 64.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 63 | 126 | $3,780 | $1,200 | 31.7% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 31 | 39 | $3,510 | $608.29 | 17.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 14 | 15 | $900.00 | $519.30 | 57.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 24 | 29 | $1,044 | $470.38 | 45.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 27 | 50 | $500.00 | $110.00 | 22.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 96 | 105 | $73,923 | $16,244 | 22.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 51 | 87 | $44,174 | $6,992 | 15.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 52 | 53 | $14,833 | $5,398 | 36.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 48 | 88 | $20,716 | $5,015 | 24.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 55 | 58 | $26,548 | $4,897 | 18.4% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 24 | 24 | $16,044 | $3,256 | 20.3% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 33 | 41 | $3,690 | $770.32 | 20.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 92 | 155 | $2,015 | $458.70 | 22.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 34 | 43 | $1,290 | $411.61 | 31.9% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 17 | 17 | $612.00 | $275.90 | 45.1% |
| 81003 | Automated urinalysis test | Office | 2022 | 27 | 45 | $450.00 | $99.74 | 22.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 64 | 67 | $38,072 | $10,651 | 28.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 102 | 183 | $28,714 | $10,335 | 36.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 54 | 92 | $33,270 | $7,699 | 23.1% |
About Dr. Jill Couch, DO
Dr. Jill Couch, DO is a Hospitalist healthcare provider based in Norton, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972561702.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jill Couch, DO has received a total of $3,346 in payments from pharmaceutical and medical device companies, with $598.90 received in 2024. These payments were reported across 179 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($3,315).
As a Medicare-enrolled provider, Couch has provided services to 2,204 Medicare beneficiaries, totaling 2,973 services with total Medicare billing of $188,103. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Other Specialties Internal Medicine
- Location Norton, VA
- Active Since 05/02/2006
- Last Updated 12/12/2025
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1972561702
Products in Payments
- ENTRESTO (Drug) $353.91
- VRAYLAR (Drug) $249.99
- LifeVest (Device) $220.14
- BREO (Drug) $203.89
- Tresiba (Drug) $174.89
- Ozempic (Drug) $171.73
- LATUDA (Drug) $153.80
- LUNA (Device) $149.11
- BREZTRI (Drug) $138.52
- MYRBETRIQ (Drug) $119.06
- EKOSONIC (Device) $109.33
- XARELTO (Drug) $101.66
- TRELEGY ELLIPTA (Drug) $98.08
- ANORO (Drug) $95.31
- SYMBICORT (Drug) $89.63
- Veozah (Drug) $70.57
- Victoza (Drug) $46.55
- JARDIANCE (Drug) $43.49
- CAPLYTA (Drug) $39.64
- MOUNJARO (Drug) $38.64
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.